Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Ortho Development Announces First Surgery Using Balanced Knee System in China

Ortho Development recently completed the first surgery using its Balanced Knee® System (BKS) in China at the Taiyuan Central Hospital in the Taiyuan, Shanxi province.

BKS implants and instrumentation address primary and revision procedures; more than 70,000 of the devices have been implanted worldwide. A patented locking mechanism is designed to minimize micro-motion between the plastic tibial insert and titanium tibial baseplates. Implants are offered in a range of sizes and options to allow anatomical fit for a variety of patients, the company says.

In July 2017, Ortho Development signed an exclusive regional distribution agreement with China Pioneer Pharma CPP for BKS. At the time, the first procedure was expected early this year; the slight delay appears to have arisen from steps necessary to gain regulatory approval. 

Ortho Development’s product focus is total hip and knee replacement, along with trauma and spine devices. The company is privately held and its majority shareholder is Japan Medical Dynamic Marketing, a publicly-traded, Japanese medical device distribution company with offices in 15 major cities and a presence in over 2,000 hospitals throughout Japan.

* Image courtesy of Ortho Development



Julie A. Vetalice, Editorial Assistant and Rob Meyer, Senior Editor, co-authored this report. Reach Rob by 
email.

4 COMMENTS

Security code
Refresh